MIAMI BEACH, Fla., April 27, 2018 -- via OTC PR WIRE -- SNM Global Holdings (OTC:SNMN) is excited to announce the assembly of a group of medical cannabis industry experts from the financial, medical, and legal sectors.
During the recent legislative session in the Maryland legislature, a bill was passed to authorize the Maryland Medical Cannabis Commission to reopen the application process and grant several additional Medical Cannabis Grower and Processor licenses throughout the state. We will be working diligently over the next several months to complete the application process, identify key areas within the state of Maryland for suitable facilities, and engage horticulture experts, as well as seasoned medical operations personnel to position SNM to be awarded either one or both of these new license opportunities.
"SNM is excited to have become involved with industry experts in each stage of the medical cannabis arena, from grow operations all the way down to retail sales at the dispensary level," stated SNM CEO Troy Lowman, "the legal counsel we have retained to assist us with our Grower and Processing applications to the Maryland Medical Cannabis Commission has a proven track record of assisting their clients in acquiring various medical cannabis licenses." “It is very humbling to realize we will be a part of a rapidly developing industry that will help so many people achieve quality of life living while with cancer and so many other diseases,” says Lowman.
The process from application to becoming fully operational is expected to take approximately 365 days.
Contact Information
Troy Lowman, CEO
Phone (410)733-6551
Email: [email protected]
Safe Harbor for Forward-Looking Statements. This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company’s current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company’s business prospect s and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commissions. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.


SpaceX Wins $1.6 Billion U.S. Space Force Launch Contracts for Falcon 9 Missions Through 2027
Sony Raises Full-Year Outlook After Q1 Profit Jumps 40% on Gaming and Chip Growth
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Same sparkle, different story: how lab-grown diamonds are transforming the market
Sony Eyes $1.3 Billion Tamron Acquisition as Lens Maker Reviews Offer
Samsung Q2 Profit Surges on AI Memory Chip Demand, Forecasts Strong Second Half
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Meta-backed research finds exposure to ‘untrustworthy’ social media is rare. The fine print is less reassuring
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat
Japan Earthquake Disrupts Auto and Chip Supply Chains
OpenAI Revenue Surges After GPT-5.6 Launch as IPO Expectations Grow
Toyota First-Half Global Sales and Production Decline on Weak China Demand, RAV4 Transition 



